SCIENTIFIC ADVISORY BOARD
Dr. Derya Unutmaz, Ph.D
Scientific Advisory Board Chairman
Scientific Advisory Board Chairman
Dr. Unutmaz is a tenured Associate Professor of Microbiology at NYU School of Medicine, New York. His groundbreaking research into the pathogenesis of HIV infection opened new vistas in immunity. He was among the original discoverers of a major breakthrough in HIV biology: that HIV uses chemokine receptors to gain entry to T cells and macrophages.
(Full C.V.)
Dr. Milton Taylor, Ph.D
Dr. Taylor received his undergraduate degree from Cornell University and his Ph.D in Biology from Stanford University, California. He is a Professor at Indiana University where he started the virology program, teaching virology and hands on laboratory for many years.
(Full C.V.)
Dr Denis Gauvreau, Ph.D
Dr. Gauvreau has been active in life sciences and technology transfer for more than 25 years. He was awarded a Ph.D in Pharmacology from the University of Cambridge (1981). His academic research activities pertained to the genetics and epidemiology of Alzheimer Disease.
(Full C.V.)
Nancy E. Wetherbee, M.B.A.
Ms. Wetherbee has more than 20 years executive experience in business development, sales and marketing in the pharmaceutical and biotech industries.
She has a strong record of achievement in creating commercial opportunities for novel biotech and genomics based discovery in both the diagnostic and pharma. (Full C.V.)
She has a strong record of achievement in creating commercial opportunities for novel biotech and genomics based discovery in both the diagnostic and pharma. (Full C.V.)
Dr. George Christakis, MSc and FRCSC
Dr. Christakis is currently Senior Scientist, Heart and Circulation Program, Sunnybrook & Women's College Health Sciences Centre, Toronto and a Professor of Surgery at the University of Toronto. He received MD and MSc from the University of Toronto and FRCSC for Cardiovascular and Thoracic Surgery.
(Full C.V.)
(Full C.V.)
Dr. Ann Prewett, Ph.D
Dr. Prewett holds a Ph.D in Chemistry from Tulane University. She is President of Replication Medical, Inc. which is developing the NeuDisc TM spinal nucleus implant for treating degenerative disc disease which is introduced into the lumbar spine using a minimally invasive approach either via a cannula or a standard microdiscectomy.
(Full C.V.)
Dr. Sunny Handa, Ph.D (Law)
Sunny Handa is a Partner and co-head of the Information Technology Group and the India Working Group at Blake, Cassels & Graydon, Montreal. He is a professor of law (adj.) at McGill University. He has a substantial practice in mergers and acquisitions of technology companies.
(Full C.V.)
Dr. Lawrence Blatt, Ph.D
Dr. Lawrence Blatt has spent the last 25 years working in drug research and development with a specific focus on biology of the immune system and relevant therapeutic antiviral and anti-cancer interventions.
(Full C.V.)
Dr. Wolfgang Renz (MD) Ph.D
Dr. Renz received his medical and academic training at the University of Freiburg Medical School, Germany. With a strong background in Clinical Research, he is presently CEO of Venn Life Sciences, a global Clinical Research Organization. He was formerly the Director, Clinical Operations for ICON Clinical Research (Canada) Inc.
(Full C.V.)
Dr. Eleanor Fish, Ph.D
Dr. Fish is the Canada Research Chair in Women’s Health & Immunobiology, a McLaughlin Scholar and was elected as a Fellow to the American Academy of Microbiologists.
(Full C.V.)
Robert J. Sexauer
Mr. Sexauer is a medical industry veteran with over 29 years of international and executive experience for medical technology firms and has worked for companies including Johnson & Johnson, Baxter International, and Marquette Electronics. Currently, he is CEO of RCP Therapeutics Ltd. RCP is an emerging nano-biotechnology company focused on nano-biomedicines.
(Full C.V.)
